Paper39057132
Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database.
Ayoub M and 7 others. Diseases, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database. Papers, record 39057132. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39057132
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36435627 | Portal vein thrombosis in patients with COVID-19: A systematic review. | Asian J Surg | 2023 | https://conductscience.org/library/papers/36435627 | PubMed |
| 2 | 32325026 | Endothelial cell infection and endotheliitis in COVID-19. | Lancet | 2020 | https://conductscience.org/library/papers/32325026 | PubMed |
| 3 | 33560401 | American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. | Blood Adv | 2021 | https://conductscience.org/library/papers/33560401 | PubMed |
| 4 | 38592411 | Portal Vein Thrombosis: State-of-the-Art Review. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592411 | PubMed |
| 5 | 38534970 | SARS-CoV-2 Infection Is an Independent Risk Factor for Decompensation in Cirrhosis Patients. | Diseases | 2024 | https://conductscience.org/library/papers/38534970 | PubMed |
| 6 | 30534594 | Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. | Transplant Direct | 2018 | https://conductscience.org/library/papers/30534594 | PubMed |
| 7 | 33503547 | Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study. | Thromb Res | 2021 | https://conductscience.org/library/papers/33503547 | PubMed |
| 8 | 32302782 | Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography. | Thromb Res | 2020 | https://conductscience.org/library/papers/32302782 | PubMed |
| 9 | 32459046 | Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32459046 | PubMed |
| 10 | 34168405 | Liver injury in COVID-19: Detection, pathogenesis, and treatment. | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/34168405 | PubMed |
| 11 | 29156209 | Changes in hemostasis in liver disease. | J Hepatol | 2017 | https://conductscience.org/library/papers/29156209 | PubMed |
| 12 | 36233500 | Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial. | J Clin Med | 2022 | https://conductscience.org/library/papers/36233500 | PubMed |
| 13 | 30221012 | Hemostasis, bleeding and thrombosis in liver disease. | J Transl Sci | 2017 | https://conductscience.org/library/papers/30221012 | PubMed |
| 14 | 32316063 | COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. | Thromb Haemost | 2020 | https://conductscience.org/library/papers/32316063 | PubMed |
| 15 | 38257786 | Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients. | Viruses | 2024 | https://conductscience.org/library/papers/38257786 | PubMed |
| 16 | 32645044 | Clinical characteristics of 82 cases of death from COVID-19. | PLoS One | 2020 | https://conductscience.org/library/papers/32645044 | PubMed |
| 17 | 35345818 | COVID-19 in Cirrhotic Patients: Is Portal Vein Thrombosis a Potential Complication? | Can J Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35345818 | PubMed |
| 18 | 35762736 | Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies. | Ther Adv Cardiovasc Dis | 2022 | https://conductscience.org/library/papers/35762736 | PubMed |
| 19 | 32734624 | Association Between Pulmonary Embolism and COVID-19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study. | Acad Emerg Med | 2020 | https://conductscience.org/library/papers/32734624 | PubMed |
| 20 | 34288441 | COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations. | Int J Lab Hematol | 2021 | https://conductscience.org/library/papers/34288441 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39057132
GET https://conductscience.org/api/papers/v1/39057132/references?page=2